Viking Therapeutics (VKTX) has seen a significant increase in its stock price, with shares reaching $57.85, up by 9.13%. The company's call options have also doubled in value, with $60 calls now at $7.60. This surge follows an upgrade and positive flow noted in the stock's performance. Stifel has highlighted VK2735, an oral dual GLP-1/GIP peptide in development, which has shown surprising tolerability. Management is confident in the drug's profile, with more data expected in the upcoming 2Q call. The stock has been a long-term position for some investors, particularly in the obesity treatment market. Risk is still 50 on this swing.
Big Pharma does not want competition or any other drug maker to take a slice of the Big pie. $LLY CEO knows what $VKTX has and the superior data in both efficacy and safety. Different bearish arguments thrown at $VKTX from manufacturing capabilities, material cost, FDA $VKTX…
$LLY pounded on this name around low 700 (though was late) $VKTX pounded on this name just over $3 Both are long term positions for Obesity in my portfolio. Cut the noise and rely on your due diligence.
$LLY $NVO Biden Saying companies need to bring price down Another political stunt before elections $VKTX Definitely more available treatments in the future good for the consumers
STIFEL $VKTX “VK2735 remains only oral dual GLP-1/GIP peptide in development with “surprising” tolerability, and management was confident that this profile remains consistent at the 60mg cohort (which is now complete)—another data point to be released on the 2Q call. 🙏👍 $XBI https://t.co/tiPLigWNBt
Viking Thera (VKTX) 57.56 +4.55 (+8.58%) 11:02 ET aug 16th $60 calls now $7.60 from $3-4 when they were sent Viking Thera (VKTX) 57.85 +4.84 (+9.13%) 11:15 ET
$VKTX call doubled! https://t.co/uRr5F1AYD9
$VKTX #Update Solid move since the upgrade and flow noted Correction, we only reclaimed 20/21 on daily clouds 50/55 EMA should be next target that you see on charts in coming sessions Risk still 50 on this swing https://t.co/vcG0QaGsBg https://t.co/i4BXK4quZf
$VKTX https://t.co/4trN9iVUJk https://t.co/m2T8AL5QZK